Insights From AMCP 2022

Conference Coverage

Analyzing Single-Arm Trial Data to Cover Drugs Granted Accelerated Approval

04/04/2022

Speakers at AMCP 2022 addressed the challenges payers face when evaluating single-arm trial data to cover drugs approved for rare diseases.

Speakers at AMCP 2022 addressed...

04/04/2022

First Report Managed Care

Conference Coverage

Real-World Data: Identifying Best Sources to Optimize Analytics

04/01/2022

Maria Asimopoulos ;

Session leaders offered tips for managed care professionals seeking to use diverse sources of real-world data to guide coverage and contract decision-making.

Session leaders offered tips for...

04/01/2022

First Report Managed Care

Conference Coverage

Pharmaceutical Manufacturers, Payers Engage in Innovative Contracts

03/31/2022

Samantha Matthews ;

Researchers presented findings at AMCP 2022 on innovative contracts among health care payers and pharmaceutical manufacturers.

Researchers presented findings...

03/31/2022

First Report Managed Care

Conference Coverage

Payer Considerations for Evaluation, Coverage, and Reimbursement of Digital Therapeutics

03/30/2022

Maria Asimopoulos ;

Presenters at AMCP 2022 recommended payers keep safety, clinical evidence, economic impact, and several other factors top of mind as the digital therapeutics space continues to expand.

Presenters at AMCP 2022...

03/30/2022

First Report Managed Care

Conference Coverage

AMCP Highlights Upcoming Legislative and Regulatory Updates

03/30/2022

Edan Stanley ;

In one of the first sessions of AMCP 2022, speakers offered updates on legislation and regulatory changes that could affect formularies and medication management decisions by health plans in the upcoming year.

In one of the first sessions of...

03/30/2022

First Report Managed Care

Conference Coverage

Medication Therapy Management Pilot Program’s Impact on Medicaid Members

03/28/2022

Maria Asimopoulos ;

Findings presented at AMCP 2022 showed the impact of a medication therapy management pilot program in Tennessee on cost savings, medication adherence, and members' resource utilization.

Findings presented at AMCP 2022...

03/28/2022

First Report Managed Care

Conference Coverage

Cost Savings, Fewer Relapses After Medication Switch for Patients With Schizophrenia

03/25/2022

Maria Asimopoulos ;

Using a hypothetical model, researchers determined switching patients from oral atypical antipsychotics to a paliperidone palmitate regimen could result in fewer relapses and significant cost savings for payers.

Using a hypothetical model,...

03/25/2022

First Report Managed Care

Conference Coverage

Disparities in Sepsis Costs, Outcomes Among Black and White Patients

03/25/2022

Maria Asimopoulos ;

Findings presented at AMCP 2022 indicated Black patients with sepsis incurred lower average costs and shorter lengths of stay in the acute care setting compared to White patients.

Findings presented at AMCP 2022...

03/25/2022

First Report Managed Care

Insights From AMCP 2022

Specialties

Events

Year Round Education

HMP Global Products